JHSM

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

EndNote Style
Index
Original Article
Evaluation and epigenetic impact of B12, vitamin D, folic acid and anemia in Hashimoto's thyroiditis: a clinical and molecular docking study
Aims: Our approach in this study is to investigate the collective effect of various parameters, including vitamin B12 (B12), vitamin D (Vit-D), folic acid, and iron deficiency, on Hashimoto's thyroiditis (HT) disease. This differs from existing literature that has examined these parameters individually.
Methods: The study evaluated age, gender, thyroid stimulating hormone (TSH), free-T4 (FT4), free-T3 (FT3), Vit-D levels, as well as autoantibodies against thyroid peroxidase (anti-TPO) and anti-tyroglobulin iron (anti-TG) levels, ferritin, B12, and folic acid parameters in a total of 30 HT patients and 37 non-HT patients. These parameters were assessed by analyzing the patients' routine blood test results using automated analysis methods.
Results: A negative correlation was found between the blood, Vit-D level and anti-TG (as the vit-D value increases, the anti-TG decreases) (r=-0.417; p=0.001; p<0.01). There was a statistically significant and weak correlation between blood Vit-D measurements and anti-TPO measurements (r=-0.341; p=0.005; p<0.01).
Conclusion: The study findings demonstrated that there was no statistically significant difference in the measurements and correlation between hemoglobin, FT3, FT4, TSH, ferritin, vitamin B12, and folic acid levels in patients with and without a diagnosis of HT (p>0.05). However, the study emphasized the critical role of vitamin D in the pathophysiology and treatment. of HT. Furthermore, molecular docking simulations indicated that folic acid could potentially act as a potent inhibitor of human extracellular signal-regulated kinase (ERK2), which has been reported to play a key role in HT.


1. Ragusa F, Fallahi P, Elia G, et al. Hashimotos&rsquo; thyroiditis:epidemiology, pathogenesis, clinic and therapy. Best Practice ResClin Endocrinol Metab. 2019;33(6):101367.
2. McLeod DS, Caturegli P, Cooper DS, et al. Variation in rates ofautoim- mune thyroid disease by race/ethnicity in US militarypersonnel. JAMA. 2014;311(15):1563-1565.
3. Rayman MP. Multiple nutritional factors and thyroid disease,with particular reference to autoimmune thyroid disease. ProcNutr Soc. 2019;78(1):34-44.
4. Kawicka A, Regulska-Ilow B. Metabolic disorders andnutritional status in autoimmune thyroid diseases. Advances inHygiene &amp; Experimental Medicine/Postepy Higieny i MedycynyDoswiadczalnej. 2015;69:80-90.
5. &Ouml;ztekin, Y, Ayaz A. Otoimm&uuml;n tiroid hastalıklarında Dvitamininin Rol&uuml;. İzmir Katip &Ccedil;elebi &Uuml;niversitesi Sağlık BilimleriFak&uuml;ltesi Derg. 2015;7(1):179-184.
6. Wiersinga WM. Clinical relevance of envi- ronmental factors inthe pathogenesis of au- toimmune thyroid disease. EndocrinolMetab. 2016;31(2):213-222.
7. Zaletel K, Gaberscek S. Hashimoto&#39;s thyroiditis:from genes to thedisease. Curr Genomics. 2011;12(8):576-588.
8. Aktaş HŞ. Vitamin B12 and Vitamin D levels in patients withautoimmune hypothyroidism and their correlation with anti-thyroid peroxidase antibodies. Med Princ Pract. 2020;29(4);364-370.
9. Elvira D. The Role of T-Regulatory Expression in AutoimmuneThyroid Disease and its association with Thyroid antibody. JAutoim Disor. 2016;2;2:19.
10. Krysia R, Szkr&oacute;bka W, Okopien B. The effect of vitamin D onthyroid autoimmunity in levothyroxine-treated women withHashimoto&rsquo;s thyroiditis and normal vitamin D status. Exp ClinEndocrinol Diabetes. 2017;125(4):229-233.
11. Hu S, Rayman MP. Multiple nutritional factors and the risk ofHashimoto&#39;s thyroiditis. Thyroid. 2017;27(5):597-610.
12. Ashraf TS, De Sanctis V, Yassin M, Wagdy M, &amp; Soliman N.Chronic anemia and thyroid function. Acta Bio Medica: AteneiParmensis. 2017;88(1):119.
13. Ko&ccedil; Ş, G&uuml;ng&ouml;r K, G&uuml;ng&ouml;r ND, Uzunlulu M. Iron deficiency inwomen with thyroid-specific autoantibodies:a case control study.J Exp Clin Med. 2022;39(1):194-198.
14. Das P, Dasnayak G, Senapati U. Cytomorphological spectrumof Hashimoto&#39;s thyroiditis and its correlatıon with clinicalpresentation, thyroid function test and antibody level. Int J SciRes. 2018;7:2277-2282.
15. Rosen Y, Daich J, Soliman I, Brathwaite E, Shoenfeld Y. Vitamin Dand autoimmunity. Scand J Rheumatol. 2016;45(6):439-447.
16. Kivity S, Agmon-Levin N, Zisappl M, et al. Vitamin D andautoimmune thyroid diseases. Cell Mol Immunol. 2011;8(3):243-247.
17. Unal AD, Tarcin O, Parildar H, et al. Vitamin D deficiency isrelated to thyroid antibodies in autoimmune thyroiditis. Cent EurJ Immunol. 2014;39(4):493-497.
18. Kim D. The role of vitamin D in thyroid diseases. Int J Mol Sci.2017;18(9):1949.
19. Mele C, Caputo M, Bisceglia A, et al. Immunomodulatory effectsof vitamin D in thyroid diseases. Nutrients. 2020;12(5):1444.
20. Rubens M, Ramamoorthy V, Saxena P, et al. Association betweenvitamin D deficiency and hypothyroidism:results from theNational Health and Nutrition Examination Survey (NHANES).2007-2012. BMC Endocr Disord. 2021;21(1):1-9.
21. Ece A, Sevin F. Exploring QSAR on 4-cyclohexylmethoxypyrimidinesas antitumor agents for their inhibitory activity of cdk2. Letters inDrug Design &amp; Discovery. 2010;7:625-631.
22. Chan K, Frankish N, Zhang T, et al. Bioactive indanes:insightinto the bioactivity of indane dimers related to the leadanti-inflammatory molecule PH46A. J Pharm Pharmacol.2020;72(7):927-937.
23. Yamali C, Gul HI, Sakarya M.T, et al. Quinazolinone-basedbenzenesulfonamides with low toxicity and high affinity asmonoamine oxidase-A inhibitors:synthesis, biological evaluationand induced-fit docking studies. Bioor Chem. 2022;124:105822.
24. Luo X, Zheng T, Mao C, et al. Aberrant MRP14 expression inthyroid follicular cells mediates chemokine secretion throughthe IL-1&beta;/MAPK pathway in Hashimoto&rsquo;s thyroiditis. EndocrConnect. 2018;7(6):850-858.
25. Gan XX, Zhong LK, Shen F, et al. Network pharmacology toexplore the molecular mechanisms of prunella vulgaris fortreating Hashimoto&rsquo;s thyroiditis. Front Pharmacol. 2021:12.
26. Beyazit Y, Kocak E, Tanoglu A, Kekilli M. Oxidative stress mightplay a role in low serum vitamin D associated liver fibrosis amongpatients with autoimmune hepatitis. Dig Dis Sci. 2015;60(4):1106-1108.
Volume 6, Issue 4, 2023
Page : 705-712
_Footer